184 related articles for article (PubMed ID: 23746695)
41. Radiotherapy and the tumor microenvironment: mutual influence and clinical implications.
Thompson RF; Maity A
Adv Exp Med Biol; 2014; 772():147-65. PubMed ID: 24272358
[TBL] [Abstract][Full Text] [Related]
42. The mechanical microenvironment in cancer: How physics affects tumours.
Nagelkerke A; Bussink J; Rowan AE; Span PN
Semin Cancer Biol; 2015 Dec; 35():62-70. PubMed ID: 26343578
[TBL] [Abstract][Full Text] [Related]
43. The Role of Glypican-1 in the Tumour Microenvironment.
Lund ME; Campbell DH; Walsh BJ
Adv Exp Med Biol; 2020; 1245():163-176. PubMed ID: 32266658
[TBL] [Abstract][Full Text] [Related]
44. Integration of EGFR inhibitors with radiochemotherapy.
Nyati MK; Morgan MA; Feng FY; Lawrence TS
Nat Rev Cancer; 2006 Nov; 6(11):876-85. PubMed ID: 17036041
[TBL] [Abstract][Full Text] [Related]
45. The changing paradigm of tumour response to irradiation.
Hill RP
Br J Radiol; 2017 Jan; 90(1069):20160474. PubMed ID: 27416998
[TBL] [Abstract][Full Text] [Related]
46. Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer.
Zhou T; Zhang LY; He JZ; Miao ZM; Li YY; Zhang YM; Liu ZW; Zhang SZ; Chen Y; Zhou GC; Liu YQ
Front Immunol; 2023; 14():1133899. PubMed ID: 36865554
[TBL] [Abstract][Full Text] [Related]
47. Exploring hypoxic biology to improve radiotherapy outcomes.
Li C; Wiseman L; Okoh E; Lind M; Roy R; Beavis AW; Pires IM
Expert Rev Mol Med; 2022 Apr; 24():e21. PubMed ID: 35586915
[TBL] [Abstract][Full Text] [Related]
48. Inflammatory microenvironment remodelling by tumour cells after radiotherapy.
McLaughlin M; Patin EC; Pedersen M; Wilkins A; Dillon MT; Melcher AA; Harrington KJ
Nat Rev Cancer; 2020 Apr; 20(4):203-217. PubMed ID: 32161398
[TBL] [Abstract][Full Text] [Related]
49. Impact of hypoxia on DNA repair and genome integrity.
Kaplan AR; Glazer PM
Mutagenesis; 2020 Feb; 35(1):61-68. PubMed ID: 31282537
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA in radiotherapy: miRage or miRador?
Korpela E; Vesprini D; Liu SK
Br J Cancer; 2015 Mar; 112(5):777-82. PubMed ID: 25611301
[TBL] [Abstract][Full Text] [Related]
51. The tumour microenvironment links complement system dysregulation and hypoxic signalling.
Olcina MM; Kim RK; Melemenidis S; Graves EE; Giaccia AJ
Br J Radiol; 2019 Jan; 92(1093):20180069. PubMed ID: 29544344
[TBL] [Abstract][Full Text] [Related]
52. Molecular targets to overcome radioresistance.
Weichselbaum RR; Beckett MA; Hallahan DE; Kufe DW; Vokes EE
Semin Oncol; 1992 Aug; 19(4 Suppl 11):14-20. PubMed ID: 1509276
[TBL] [Abstract][Full Text] [Related]
53. Perfusion-Limited Hypoxia Determines the Outcome of Radiation Therapy of Hypoxic Tumours.
Schiavo F; Toma-Dasu I; Lindblom EK
Adv Exp Med Biol; 2022; 1395():249-254. PubMed ID: 36527645
[TBL] [Abstract][Full Text] [Related]
54. Drug radiotherapy combinations: review of previous failures and reasons for future optimism.
Higgins GS; O'Cathail SM; Muschel RJ; McKenna WG
Cancer Treat Rev; 2015 Feb; 41(2):105-13. PubMed ID: 25579753
[TBL] [Abstract][Full Text] [Related]
55. Microenvironment-induced cancer metastasis.
Rofstad EK
Int J Radiat Biol; 2000 May; 76(5):589-605. PubMed ID: 10866281
[TBL] [Abstract][Full Text] [Related]
56. Emerging Role of EGFR Mutations in Creating an Immune Suppressive Tumour Microenvironment.
Kapoor SS; Zaiss DMW
Biomedicines; 2021 Dec; 10(1):. PubMed ID: 35052732
[TBL] [Abstract][Full Text] [Related]
57. Radioresistant tumours: From identification to targeting.
Cohen-Jonathan-Moyal É; Vendrely V; Motte L; Balosso J; Thariat J
Cancer Radiother; 2020 Oct; 24(6-7):699-705. PubMed ID: 32753241
[TBL] [Abstract][Full Text] [Related]
58. Radiation treatment effects on the proteome of the tumour microenvironment.
Atkinson MJ
Adv Exp Med Biol; 2013; 990():49-60. PubMed ID: 23378002
[TBL] [Abstract][Full Text] [Related]
59. Clinically relevant biomarkers in targeted radiotherapy.
Stea B; Gordon J
Clin Exp Metastasis; 2012 Oct; 29(7):853-60. PubMed ID: 22886523
[TBL] [Abstract][Full Text] [Related]
60. A Review of the Role of Hypoxia in Radioresistance in Cancer Therapy.
Bouleftour W; Rowinski E; Louati S; Sotton S; Wozny AS; Moreno-Acosta P; Mery B; Rodriguez-Lafrasse C; Magne N
Med Sci Monit; 2021 Nov; 27():e934116. PubMed ID: 34728593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
